PBI13 Cost-Minimization Analysis and Budget Impact of Upadacitinib in the Treatment of Rheumatoid Arthritis in the Brazilian Public Health System

Abstract

Authors

R. Acayaba de Toledo M.S. Arruda C.G.V. Morais R. dos Santos

Full Text Cite This Article
Back to Volume 24, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×